1180 related articles for article (PubMed ID: 33075159)
1. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
2. Insulin and oral agents for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2016 Apr; 4():CD004730. PubMed ID: 27087121
[TBL] [Abstract][Full Text] [Related]
3. Insulin and oral agents for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2013 Jul; (7):CD004730. PubMed ID: 23893261
[TBL] [Abstract][Full Text] [Related]
4. Insulin and oral agents for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2005 Jul; (3):CD004730. PubMed ID: 16034943
[TBL] [Abstract][Full Text] [Related]
5. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
6. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
Lands LC; Stanojevic S
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD001505. PubMed ID: 31499593
[TBL] [Abstract][Full Text] [Related]
7. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Carter B; Putman M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD008901. PubMed ID: 30557452
[TBL] [Abstract][Full Text] [Related]
8. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
10. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
[TBL] [Abstract][Full Text] [Related]
12. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
[TBL] [Abstract][Full Text] [Related]
13. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Aslam AA; Higgins C; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD012040. PubMed ID: 28102546
[TBL] [Abstract][Full Text] [Related]
14. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
[TBL] [Abstract][Full Text] [Related]
15. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
[TBL] [Abstract][Full Text] [Related]
16. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Carter B; Putman M
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD008901. PubMed ID: 34424546
[TBL] [Abstract][Full Text] [Related]
17. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
Southern KW; Solis-Moya A; Kurz D; Smith S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
[TBL] [Abstract][Full Text] [Related]
18. Oral calorie supplements for cystic fibrosis.
Smyth RL; Rayner O
Cochrane Database Syst Rev; 2017 May; 5(5):CD000406. PubMed ID: 28470972
[TBL] [Abstract][Full Text] [Related]
19. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
[TBL] [Abstract][Full Text] [Related]
20. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
